Efinaconazole(formerly AGJ-95634; KP-103; CTK-5J2975; KB-145948; trade names Jublia; Clenafin) is a triazole antifungal drug approved for use in various countries such as the United States, Canada, and Japan as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nails). It acts as an inhibitor of 14α-demethylase, which is involved in the biosynthesis of ergosterol, a key constituent of fungal cell membranes.

纯度：≥98%

CAS：164650-44-6